CONMED Corporation (CNMD)
NYSE: CNMD · Real-Time Price · USD
46.30
-0.68 (-1.45%)
At close: Jul 31, 2026, 4:00 PM EDT
46.05
-0.25 (-0.54%)
After-hours: Jul 31, 2026, 7:34 PM EDT
CONMED Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 37.33 | 40.82 | 24.46 | 24.3 | 28.94 | 20.85 |
Cash & Short-Term Investments | 37.33 | 40.82 | 24.46 | 24.3 | 28.94 | 20.85 |
Cash Growth | 10.00% | 66.88% | 0.67% | -16.05% | 38.83% | -23.79% |
Accounts Receivable | 239.77 | 247.83 | 237.73 | 242.28 | 191.35 | 183.88 |
Inventory | 360.18 | 355.54 | 346.72 | 318.32 | 332.32 | 231.64 |
Other Current Assets | 38.39 | 28.67 | 31.1 | 30.75 | 28.62 | 23.75 |
Total Current Assets | 675.67 | 672.86 | 640.01 | 615.65 | 581.23 | 460.12 |
Net Property, Plant & Equipment | 110.14 | 113.33 | 115.79 | 120.72 | 115.61 | 108.86 |
Other Intangible Assets | 564.42 | 582.05 | 617.66 | 649.48 | 681.8 | 471.05 |
Goodwill | 796.9 | 807.01 | 805.36 | 806.84 | 815.43 | 617.53 |
Other Long-Term Assets | 153.18 | 150.5 | 127.43 | 107.32 | 103.53 | 108.45 |
Total Assets | 2,300 | 2,326 | 2,306 | 2,300 | 2,298 | 1,766 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 101.02 | 93.65 | 102.25 | 88.22 | 73.39 | 58.2 |
Accrued Expenses | 70.42 | 82.14 | 65.37 | 70.07 | 54.73 | 60.49 |
Current Portion of Long-Term Debt | 177.2 | 0.71 | 0.72 | 0.71 | 69.75 | 12.25 |
Other Current Liabilities | 106.77 | 138.54 | 109.8 | 151.73 | 98.68 | 65.71 |
Total Current Liabilities | 455.4 | 315.04 | 278.13 | 310.73 | 296.55 | 196.65 |
Long-Term Debt | 657.05 | 834.23 | 905.07 | 973.14 | 985.08 | 672.41 |
Other Long-Term Liabilities | 146.47 | 143.38 | 160.37 | 181.93 | 270.42 | 111.53 |
Total Long-Term Liabilities | 803.52 | 977.61 | 1,065 | 1,155 | 1,255 | 783.94 |
Total Liabilities | 1,259 | 1,293 | 1,344 | 1,466 | 1,552 | 980.58 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 | 0.31 |
Treasury Stock | -54.68 | -12.89 | -15.63 | -14.99 | -22.78 | -54.05 |
Additional Paid-in Capital | 513.46 | 503.2 | 476.58 | 446.54 | 413.24 | 396.77 |
Accumulated Other Comprehensive Income | -43.37 | -46.3 | -58.86 | -50.17 | -57.86 | -54.2 |
Retained Earnings | 625.67 | 588.77 | 560.28 | 452.53 | 412.63 | 496.61 |
Shareholders' Equity | 1,041 | 1,033 | 962.68 | 834.22 | 745.55 | 785.44 |
Total Liabilities & Equity | 2,300 | 2,326 | 2,306 | 2,300 | 2,298 | 1,766 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 834.25 | 834.94 | 905.78 | 973.85 | 1,055 | 684.66 |
Net Cash (Debt) | -796.92 | -794.13 | -881.32 | -949.55 | -1,026 | -663.81 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -25.95 | -25.49 | -28.29 | -30.10 | -34.15 | -20.61 |
Book Value | 1,041 | 1,033 | 962.68 | 834.22 | 745.55 | 785.44 |
Book Value Per Share | 33.92 | 33.17 | 30.90 | 26.44 | 24.82 | 24.38 |
Tangible Book Value | -319.93 | -355.97 | -460.34 | -622.11 | -751.68 | -303.14 |
Tangible Book Value Per Share | -10.42 | -11.43 | -14.78 | -19.72 | -25.02 | -9.41 |